The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg / 2.5mg per ml Solution for Injection

0.5mg /2.5 milligram(s)/millilitre Solution for injection

MercuryPharm LtdPA0857/002/001

Main Information

Trade NameGlycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg / 2.5mg per ml Solution for Injection
Active SubstancesGlycopyrronium bromide
Neostigmine Metilsulfate
Strength0.5mg /2.5 milligram(s)/millilitre
Dosage FormSolution for injection
Licence HolderMercuryPharm Ltd
Licence NumberPA0857/002/001

Group Information

ATC CodeN07AA Anticholinesterases
N07AA51 neostigmine, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued07/11/1986
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back